USE OF MYELOID PROGENITOR CELL GRAFT IN MANUFACTURE OF A MEDICAMENT FOR ENHANCING ENGRAFTMENT OF A SUBOPTIMAL HEMATOPOIETIC STEM CELLS GRAFT

摘要

The present disclosure relates to the field of hematopoietic stem cell transplantation. More specifically, methods, compositions and kits for improving engraftment of stem cell transplants by administering myeloid progenitor cells are provided.